Michael E Newcomb1, Michelle Birkett, Heather L Corliss, Brian Mustanski. 1. Michael E. Newcomb, Michelle Birkett, and Brian Mustanski are with the Department of Medical Social Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL. Heather L. Corliss is with Children's Hospital of Boston and Harvard Medical School, Boston, MA.
Abstract
OBJECTIVES: We evaluated drug use differences between sexual minority and heterosexual students, including interactions with gender and race/ethnicity. METHODS: We used 2005 and 2007 Youth Risk Behavior Survey data pooled from Boston, Massachusetts; Chicago, Illinois; Delaware; Maine; Massachusetts; New York City, New York; Rhode Island; and Vermont to evaluate drug use (marijuana, cocaine, inhalants, heroin, methamphetamine, and MDMA [Ecstasy]) using 2 aspects of sexual orientation (identity and sex of sexual partners). RESULTS: Sexual minority students had higher prevalence of drug use than did heterosexuals on both sexual orientation dimensions, and differences were particularly pronounced among bisexual students on both dimensions. Differences between sexual minority and heterosexual male students in prevalence were generally larger than were differences between sexual minority and heterosexual female students. Racial minority students generally reported lower prevalence of drug use. However, the protective effect of African American race was less pronounced for some sexual minorities. CONCLUSIONS: Sexual minority youths are at increased risk for drug use. Intervention is needed at the institutional and individual levels to address these disparities.
OBJECTIVES: We evaluated drug use differences between sexual minority and heterosexual students, including interactions with gender and race/ethnicity. METHODS: We used 2005 and 2007 Youth Risk Behavior Survey data pooled from Boston, Massachusetts; Chicago, Illinois; Delaware; Maine; Massachusetts; New York City, New York; Rhode Island; and Vermont to evaluate drug use (marijuana, cocaine, inhalants, heroin, methamphetamine, and MDMA [Ecstasy]) using 2 aspects of sexual orientation (identity and sex of sexual partners). RESULTS: Sexual minority students had higher prevalence of drug use than did heterosexuals on both sexual orientation dimensions, and differences were particularly pronounced among bisexual students on both dimensions. Differences between sexual minority and heterosexual male students in prevalence were generally larger than were differences between sexual minority and heterosexual female students. Racial minority students generally reported lower prevalence of drug use. However, the protective effect of African American race was less pronounced for some sexual minorities. CONCLUSIONS: Sexual minority youths are at increased risk for drug use. Intervention is needed at the institutional and individual levels to address these disparities.
Authors: Brian Mustanski; Aimee Van Wagenen; Michelle Birkett; Sandra Eyster; Heather L Corliss Journal: Am J Public Health Date: 2013-12-12 Impact factor: 9.308
Authors: John M Wallace; Jerald G Bachman; Patrick M O'Malley; Lloyd D Johnston; John E Schulenberg; Shauna M Cooper Journal: Public Health Rep Date: 2002 Impact factor: 2.792
Authors: John M Wallace; Jerald G Bachman; Patrick M O'Malley; John E Schulenberg; Shauna M Cooper; Lloyd D Johnston Journal: Addiction Date: 2003-02 Impact factor: 6.526
Authors: Robert W S Coulter; James E Egan; Suzanne Kinsky; M Reuel Friedman; Kristen L Eckstrand; Jessica Frankeberger; Barbara L Folb; Christina Mair; Nina Markovic; Anthony Silvestre; Ron Stall; Elizabeth Miller Journal: Pediatrics Date: 2019-08-19 Impact factor: 7.124
Authors: Gregory Phillips Ii; Dylan Felt; David J McCuskey; Rachel Marro; Jacob Broschart; Michael E Newcomb; Sarah W Whitton Journal: Addict Behav Date: 2020-03-28 Impact factor: 3.913